Projects per year
Abstract
BACKGROUND: Little is known about potential confounding factors influencing the humoral response in individuals having received the BNT162b2 vaccine.
METHODS: Blood samples from 231 subjects were collected before and 14, 28, and 42 days following coronavirus disease 2019 (COVID-19) vaccination with BNT162b2. Anti-spike receptor-binding-domain protein (anti-Spike/RBD) immunoglobulin G (IgG) antibodies were measured at each time-point. Impact of age, sex, childbearing age status, hormonal therapy, blood group, body mass index and past-history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were assessed by multivariable analyses.
RESULTS AND CONCLUSIONS: In naïve subjects, the level of anti-Spike/RBD antibodies gradually increased following administration of the first dose to reach the maximal response at day 28 and then plateauing at day 42. In vaccinated subjects with previous SARS-CoV-2 infection, the plateau was reached sooner (i.e., at day 14). In the naïve population, age had a significant negative impact on anti-Spike/RBD titers at days 14 and 28 while lower levels were observed for males at day 42, when corrected for other confounding factors. Body mass index (BMI) as well as B and AB blood groups had a significant impact in various subgroups on the early response at day 14 but no longer after. No significant confounding factors were highlighted in the previously infected group.
Original language | English |
---|---|
Article number | 1340 |
Journal | Microorganisms |
Volume | 9 |
Issue number | 6 |
DOIs | |
Publication status | Published - 21 Jun 2021 |
Keywords
- Age
- Antibody
- Blood-group
- BMI
- BNT162b2
- Gender
- Kinetic
- SARS-CoV-2
- Serology
- Vaccine
Fingerprint
Dive into the research topics of 'Confounding factors influencing the kinetics and magnitude of serological response following administration of BNT162b2'. Together they form a unique fingerprint.Projects
- 1 Active
-
The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J., Dogne, J., FAVRESSE, J., Tre-Hardy, M., Mullier, F., Haguet, H., Hardy, M., Melchionda, S., BOUVY, C., Morimont, L., Gillot, C., Djokoto, H., Alpan, L., Devel, P., Modaffari, E. & Maloteau, V.
13/03/20 → …
Project: Research